In a major shift for women’s health, the Food and Drug Administration (FDA) has announced it will remove the prominent “black box” warning from many hormone therapies used to treat menopause symptoms.

The FDA is removing the "black box" warning from many hormone therapies for menopause symptoms, citing new research showing lower risks for women under 60 or within 10 years of menopause. This shift ...